Further MT for Antibiotic-Resistant Bacterial Colonization
NCT05835206
This study is recruiting at 6 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to better understand the effectiveness and safety of microbiome therapies (MT) as a treatment for patients with Multidrug Resistant Organism (MDRO) colonization after an infection. Limited data from prior studies suggest that MT may be an effective treatment to reduce intestinal MDRO colonization Although shedding of MDROs from patients to their surrounding environment is a recognized pathway of transmission, the potential effect of MT on the transmission of MDRO to other patients in the hospital environment is unclear.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Intestinal Multi-drug Resistant Organism Colonization
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Emory University
- Last updated on ClinicalTrials.gov
- May 6, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Georgia · 6
- Emory Rehabilitation Hospital · Atlanta, GA
- Emory University at Wesley Woods Hospital · Atlanta, GA
- Emory University Clinical Research Network · Atlanta, GA
- Emory University Hospital (EUH) · Atlanta, GA
- Emory University Hospital Midtown · Atlanta, GA
- Emory Johns Creek Hospital · Johns Creek, GA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.